Business Context and Reporting Period
This Form 8-K Current Report was filed by Mitcham Industries, Inc. (noted as "MIND TECHNOLOGY, INC" in metadata) on July 12, 2007. The report details corporate governance actions taken on this date, including the approval of equity compensation plans and the results of the Annual Meeting of Shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and equity compensation events rather than financial performance.
Material Changes and Corporate Actions
Equity Compensation Awards
- Non-Employee Director Stock Options: Approved on July 12, 2007. Options vest over three years (one-third annually).
- Peter Blum: 60,000 shares
- John Schwalbe: 30,000 shares
- R. Dean Lewis: 30,000 shares
- Exercise Price: $20.00 per share
- Officer Restricted Stock: Approved on July 12, 2007. Stock vests over three years (one-third annually).
- Billy F. Mitcham, Jr.: 6,000 shares
- Robert P. Capps: 2,000 shares
- P. Guy Rogers: 2,000 shares
- Guy Malden: 2,000 shares
Annual Meeting of Shareholders Results
Held on July 12, 2007, with a record date of May 21, 2007.
- Director Elections: All five nominees were elected.
- Billy F. Mitcham, Jr.: 8,229,026 For / 221,399 Withheld
- R. Dean Lewis: 8,294,759 For / 156,666 Withheld
- John F. Schwalbe: 8,294,353 For / 156,072 Withheld
- Robert P. Capps: 8,093,906 For / 356,519 Withheld
- Peter H. Blum: 8,294,416 For / 156,009 Withheld
- Auditor Ratification: Hein & Associates LLP was ratified as independent auditors.
- For: 8,254,444
- Against: 189,367
- Abstaining: 6,614
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the specific events of the Annual Meeting and the Board's compensation approvals.
Investor Verification Checklist
- Verify the total number of outstanding shares to assess the dilution impact of the new 122,000 options and 12,000 restricted shares.
- Confirm the current market price of the stock relative to the $20.00 exercise price of the newly granted options.
- Review the Company's most recent 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.
- Check for any subsequent filings regarding the vesting schedules or potential forfeiture of the awarded equity.